Suppr超能文献

生物材料介导的免疫系统工程

Biomaterials-Mediated Engineering of the Immune System.

机构信息

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA; email:

Departments of Biological Engineering and Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

出版信息

Annu Rev Immunol. 2023 Apr 26;41:153-179. doi: 10.1146/annurev-immunol-101721-040259. Epub 2023 Jan 25.

Abstract

Modulation of the immune system is an important therapeutic strategy in a wide range of diseases, and is fundamental to the development of vaccines. However, optimally safe and effective immunotherapy requires precision in the delivery of stimulatory cues to the right cells at the right place and time, to avoid toxic overstimulation in healthy tissues or incorrect programming of the immune response. To this end, biomaterials are being developed to control the location, dose, and timing of vaccines and immunotherapies. Here we discuss fundamental concepts of how biomaterials are used to enhance immune modulation, and evidence from preclinical and clinical studies of how biomaterials-mediated immune engineering can impact the development of new therapeutics. We focus on immunological mechanisms of action and in vivo modulation of the immune system, and we also discuss challenges to be overcome to speed translation of these technologies to the clinic.

摘要

免疫系统的调节是广泛疾病治疗的重要策略,也是疫苗发展的基础。然而,为了实现最佳的安全性和有效性,免疫疗法需要精确地将刺激信号递送到正确的细胞,在正确的位置和时间,以避免在健康组织中产生毒性的过度刺激或免疫反应的错误编程。为此,正在开发生物材料来控制疫苗和免疫疗法的位置、剂量和时间。在这里,我们讨论了生物材料如何用于增强免疫调节的基本概念,以及临床前和临床研究中生物材料介导的免疫工程如何影响新疗法的发展的证据。我们重点讨论了免疫作用机制和体内免疫系统的调节,还讨论了为加快这些技术向临床转化而需要克服的挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f294/10375298/28a5b2bfdf06/nihms-1913725-f0001.jpg

相似文献

1
Biomaterials-Mediated Engineering of the Immune System.生物材料介导的免疫系统工程
Annu Rev Immunol. 2023 Apr 26;41:153-179. doi: 10.1146/annurev-immunol-101721-040259. Epub 2023 Jan 25.
3
Harnessing Biomaterials to Study and Direct Antigen-Specific Immunotherapy.利用生物材料研究和指导抗原特异性免疫疗法。
ACS Appl Bio Mater. 2023 Jun 19;6(6):2017-2028. doi: 10.1021/acsabm.3c00136. Epub 2023 Apr 17.
6
Biomaterials as Tools to Decode Immunity.生物材料作为解码免疫的工具。
Adv Mater. 2020 Apr;32(13):e1903367. doi: 10.1002/adma.201903367. Epub 2019 Nov 29.
9
Engineering vaccines and niches for immune modulation.设计用于免疫调节的疫苗和生态位。
Acta Biomater. 2014 Apr;10(4):1728-40. doi: 10.1016/j.actbio.2013.12.036. Epub 2013 Dec 27.
10
Engineering Immune Tolerance with Biomaterials.工程化免疫耐受的生物材料策略
Adv Healthc Mater. 2019 Feb;8(4):e1801419. doi: 10.1002/adhm.201801419. Epub 2019 Jan 3.

引用本文的文献

2
Advances in molecular pathology and therapy of non-small cell lung cancer.非小细胞肺癌分子病理学与治疗的进展
Signal Transduct Target Ther. 2025 Jun 15;10(1):186. doi: 10.1038/s41392-025-02243-6.
3
Diverse priming outcomes under conditions of very rare precursor B cells.在极罕见的前体B细胞条件下的多种启动结果。
Immunity. 2025 Apr 8;58(4):997-1014.e11. doi: 10.1016/j.immuni.2025.03.003. Epub 2025 Mar 31.
6
Cell-Instructive Biomaterials with Native-Like Biochemical Complexity.具有类天然生化复杂性的细胞指导性生物材料。
Annu Rev Biomed Eng. 2025 May;27(1):185-209. doi: 10.1146/annurev-bioeng-120823-020209. Epub 2025 Jan 28.
7
Recombinant fibrous protein biomaterials meet skin tissue engineering.重组纤维蛋白生物材料适用于皮肤组织工程。
Front Bioeng Biotechnol. 2024 Aug 14;12:1411550. doi: 10.3389/fbioe.2024.1411550. eCollection 2024.
8
Tailoring biomaterials for vaccine delivery.为疫苗传递量身定制生物材料。
J Nanobiotechnology. 2024 Aug 12;22(1):480. doi: 10.1186/s12951-024-02758-0.

本文引用的文献

6
Landscape of cancer cell therapies: trends and real-world data.癌细胞疗法全景:趋势与真实世界数据
Nat Rev Drug Discov. 2022 Sep;21(9):631-632. doi: 10.1038/d41573-022-00095-1.
8
Engineered cellular immunotherapies in cancer and beyond.癌症及其他领域的工程化细胞免疫疗法。
Nat Med. 2022 Apr;28(4):678-689. doi: 10.1038/s41591-022-01765-8. Epub 2022 Apr 19.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验